-Reuters
Health Care Company Rocket Pharmaceuticals Announces Acquisition of Renovacor
Rocket Pharmaceuticals (NASDAQ:RCKT) has announced an acquisition of Renovacor (AMEX:RCOR) that is expected to be completed in Q1 of 2023.
Related Posts
Poland And U.K. Regulatory Authorities URPL And MHRA Approve Use Of New, Higher-Yielding Manufacturing Process For Nomacopan In Pivotal Clinical Study
Third generation drug substance manufacturing process increases the final yield of nomacopan by at least 5-fold, improving cost efficiencies in the continuing Phase 3 clinical trial of nomacopan in pediatric
Broadwind Names Thomas A. Ciccone New Finance Chief
Broadwind Inc (NASDAQ: BWEN) has appointed Thomas A. Ciccone as Vice President, Chief Financial Officer, and Principal Financial Officer, effective August…
Barclays Maintains Overweight on Cintas, Raises Price Target to $500
Barclays analyst Manav Patnaik maintains Cintas (NASDAQ:CTAS) with a Overweight and raises the price target from $435 to $500.